Literature DB >> 26298926

Cost Analysis of Adult Male Circumcision with the PrePex Device versus Surgery in Rwanda.

Vincent Mutabazi, Jean Paul Bitega, Leon Muyenzi Ngeruka, Jean Pierre Nyemazi, Mary Dain, Steven A Kaplan, Corine Karema, Agnes Binagwaho.   

Abstract

In this study from Rwanda, voluntary adult male circumcision costs 33% less with trained nurses using the PrePex device compared with physician-nurse teams performing dorsal-slit surgery. These cost savings and the documented safety, speed, and efficacy of the PrePex procedure, serve Rwanda's HIV prevention program.

Entities:  

Mesh：

Year:  2014        PMID： 26298926

Source DB:  PubMed          Journal:  Urol Nurs        ISSN： 1053-816X


  3 in total

1.  The characteristics of circular disposable devices and in situ devices for optimizing male circumcision: a network meta-analysis.

Authors:  Yu Fan; Dehong Cao; Qiang Wei; Zhuang Tang; Ping Tan; Lu Yang; Liangren Liu; Zhenhua Liu; Xiang Li; Wenbin Xue
Journal:  Sci Rep       Date:  2016-05-09       Impact factor: 4.379

2.  Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe.

Authors:  Mufuta Tshimanga; Batsirai Makunike-Chikwinya; Tonderayi Mangwiro; Patricia Tapiwa Gundidza; Pesanai Chatikobo; Vernon Murenje; Amy Herman-Roloff; Peter H Kilmarx; Marrianne Holec; Gerald Gwinji; Owen Mugurungi; Munyaradzi Murwira; Sinokuthemba Xaba; Scott Barnhart; Caryl Feldacker
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

3.  Cost and Cost-Effectiveness of a Demand Creation Intervention to Increase Uptake of Voluntary Medical Male Circumcision in Tanzania: Spending More to Spend Less.

Authors:  Sergio Torres-Rueda; Mwita Wambura; Helen A Weiss; Marya Plotkin; Katharine Kripke; Joseph Chilongani; Hally Mahler; Evodius Kuringe; Maende Makokha; Augustino Hellar; Carl Schutte; Kokuhumbya J Kazaura; Daimon Simbeye; Gerry Mshana; Natasha Larke; Gissenge Lija; John Changalucha; Anna Vassall; Richard Hayes; Jonathan M Grund; Fern Terris-Prestholt
Journal:  J Acquir Immune Defic Syndr       Date:  2018-07-01       Impact factor: 3.731
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.